Clinical Trial Update: Pilocarpine After Combined Cataract/Trabectome Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial of pilocarpine after combined cataract/trabectome surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Pilocarpine (pilocarpine)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: WITHDRAWN